Closing Figures Unveiled: Rocket Pharmaceuticals Inc (RCKT) Drop -1.47, Closes at 24.20

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $24.20 down -1.47% from the previous closing price of $24.56. In other words, the price has decreased by -$1.47 from its previous closing price. On the day, 0.6 million shares were traded. RCKT stock price reached its highest trading level at $24.7416 during the session, while it also had its lowest trading level at $23.87.

Ratios:

For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.47 and its Current Ratio is at 10.47. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Neutral rating and assigned the stock a target price of $39.

On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $65.

On February 01, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $45.Morgan Stanley initiated its Overweight rating on February 01, 2023, with a $45 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 22 ’24 when Militello John sold 812 shares for $23.02 per share. The transaction valued at 18,688 led to the insider holds 52,515 shares of the business.

White Mark Andrew sold 3,026 shares of RCKT for $61,715 on Jul 08 ’24. The insider now owns 72,220 shares after completing the transaction at $20.39 per share. On May 16 ’24, another insider, Shah Gaurav, who serves as the CEO of the company, sold 9,790 shares for $23.35 each. As a result, the insider received 228,596 and left with 728,069 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 2207664384 and an Enterprise Value of 1925247104.

Stock Price History:

Over the past 52 weeks, RCKT has reached a high of $32.53, while it has fallen to a 52-week low of $14.89. The 50-Day Moving Average of the stock is 8.17%, while the 200-Day Moving Average is calculated to be -1.17%.

Shares Statistics:

Over the past 3-months, RCKT traded about 784.43K shares per day on average, while over the past 10 days, RCKT traded about 693790 shares per day. A total of 90.28M shares are outstanding, with a floating share count of 83.69M. Insiders hold about 7.81% of the company’s shares, while institutions hold 99.61% stake in the company. Shares short for RCKT as of 1721001600 were 9642489 with a Short Ratio of 12.29, compared to 1718323200 on 9262160. Therefore, it implies a Short% of Shares Outstanding of 9642489 and a Short% of Float of 22.600001.

Most Popular